We examined the partitioning of total lung resistance (RL) into airway resi
stance (Raw) and tissue resistance (Rti) in patients with mild to moderate
asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol i
nhalation. An optimal ventilator waveform was used to measure RL and lung e
lastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal
excursions. Analysis of the RL and EL provided separate estimates of airway
and lung tissue properties. Eleven subjects, classified as Type A asthmati
cs, displayed slightly elevated RL but normal EL. Their data were well desc
ribed with a model consisting of homogeneous airways leading to viscoelasti
c tissues before and after albuterol. The other 10 subjects, classified as
Type B asthmatics, demonstrated highly elevated RL and an EL. that became h
ighly elevated at frequencies above 2 Hz. These subjects required the inclu
sion of an airway wall compliance in the model prealbuterol but not postalb
uterol. This suggests that the Type B subjects were experiencing pronounced
constriction in the periphery of the lung, resulting in shunting of flow i
nto the airway walls. Spirometric data were consistent with higher constric
tion in Type B subjects. Both groups demonstrated significant (p < 0.05) de
creases in Raw and tissue damping after albuterol, but tissue elastance dec
reased only in the Type B group. The percent contributions of Raw and Rti t
o RL were similar in both groups and did not change after albuterol. We con
clude that in asthma, Raw comprises the majority (> 70%) of RL at breathing
frequencies. The relative contributions of Raw and Rti to RL appear to be
independent of the degree of smooth muscle constriction.